News Archives
These press releases speak only as of the date issued as indicated on the releases. Senomyx undertakes no obligation to update or supplement any information contained in these press releases.La Jolla , CA ( October 7, 2003 ) – Senomyx, Inc. (www.senomyx.com) announced today that John W. Poyhonen has joined the Company as Vice President and Chief Business Officer. Mr. Poyhonen has over 20 years of diverse sales, marketing and general business experience in the biotechnology, pharmaceutical and diagnostic industries. He will serve as a member of the Company's senior management team. more
La Jolla , CA ( September 18, 2003 ) – Senomyx, Inc. (www.senomyx.com) announced the appointment of Harry J. Leonhardt, Esq. to the position of Vice President and General Counsel. Mr. Leonhardt brings over 20 years of legal, corporate, intellectual property and business development experience to the Company. Mr. Leonhardt will head Senomyx's Legal Department and serve as a member of the Company's senior management team. more
La Jolla, CA (June 30, 2003) – Senomyx, Inc. (www.senomyx.com) announced today that Kent Snyder has joined the Company as President and Chief Executive Officer. Mr. Snyder will also serve as a member of the Company's Board of Directors. Mr. Snyder has over 20 years of management experience in the pharmaceutical and biotechnology industries with Hoffmann-La Roche Inc., Marion Merrell Dow, Inc., and most recently Agouron Pharmaceuticals, Inc. He brings to Senomyx significant expertise and experience in all aspects of commercial operations, including strategic planning, business development, and sales and marketing. more
La Jolla, CA (May 7, 2002) – Senomyx, Inc. (www.senomyx.com) today announced an agreement with The Coca-Cola Company to research new flavors of soft drinks and other nonalcoholic beverages. Specific terms of the agreement were not disclosed. more
La Jolla, CA (May 6, 2002) – Senomyx, Inc. (www.senomyx.com) announced today an exclusive collaborative research and license agreement for the discovery and commercialization of new ingredients that will enhance taste of specified consumer food products. Exact terms of the collaboration were not disclosed. However, under the agreement, Nestlé will provide research funding over a three-year period and, upon successful outcome of the research, additional payments for milestones and for royalties based on sales of products using the new ingredients. more
La Jolla, CA (April 2, 2002) – Scientists at Senomyx, Inc. (www.senomyx.com) have demonstrated the function of a human receptor that responds to sweeteners and a related human receptor that responds to glutamate, a savory tasting molecule found in a variety of meats, cheeses and vegetables and associated with umami taste. These results are described in a manuscript to be published in the April 2, 2002 issue of the Proceedings of the National Academy of Sciences (www.pnas.org) and will be presented at the annual meeting of the Association for Chemoreception Sciences beginning on April 24, 2002 in Sarasota, Florida. more
LA JOLLA, CA (March 11 , 2002) – Senomyx, Inc. (www.senomyx.com) announced today the completion of a $36,837,000 private placement of Series E preferred stock. These funds will be used to expand and accelerate the Company's research and development efforts toward developing new technologies to improve the world of taste and smell. more
LA JOLLA, CA (June 1, 2001) – Scientists at Senomyx, Inc. (www.senomyx.com) have identified a set of 347 human olfactory receptor genes, which the Company believes represents substantially the complete set of functional receptors related to smell. A manuscript describing this work will be published in the June 2001 issue of the journal Genome Biology (www.genomebiology.com). more
LA JOLLA, CA (May 22, 2001) – Senomyx, Inc. (www.senomyx.com) announced today that Paul A. Grayson has been appointed to the position of Chief Executive Officer and Chairman of the Board of Directors and Dr. Mark Zoller to the position of Chief Scientific Officer and Vice President of Research. Dr. Lubert Stryer, who returns to Stanford University following a two-year leave at Senomyx, relinquishes his position as Chairman of the Board and Chief Scientific Officer. more
LA JOLLA, CA and Camden, NJ (April 23, 2001) – SenomyxSM, Inc. (www.senomyx.com) and Campbell Soup Company (NYSE: CPB) announced today an exclusive collaborative research and license agreement for the discovery and commercialization of new ingredients that improve the taste of wet soups. Exact terms of the collaboration were not disclosed. However, under the agreement Campbell Soup Company will provide research funding over a three-year period and, upon successful outcome of the research, additional payments for milestones and for royalties based on net sales of products using the new ingredients. more
LA JOLLA, CA (April 23, 2001) – Scientists at SenomyxSM Inc. (www.senomyx.com) have identified hT1R3, a candidate human taste receptor for sweet tastants. Dr. Elliot Adler from Senomyx will present this and other work at the annual meeting of AChemS on Thursday, April 26, 2001 in Sarasota, Florida. The new candidate receptor was identified by Dr. Adler and his colleague Dr. Sergey Zozulya using a bioinformatics analysis of unannotated human genome sequence databases to identify the gene sequence encoding the new receptor. more
LA JOLLA, CA (Jan. 4, 2001) – SenomyxSM, Inc. announced today it has licensed Incyte's gene sequence database for use in the discovery of genes involved in taste, olfaction, and the detection of pheromones. more
LA JOLLA, CA (Dec. 11, 2000) – SenomyxSM, Inc. announced today that it will work with Kraft Foods, Inc. to discover new ingredients that improve and enhance taste using proprietary Senomyx technology. more
LA JOLLA, CA (Nov. 1, 2000) – Aurora Biosciences™ Corporation and SenomyxSM, Inc. today announced that they have signed an exclusive collaborative research and license agreement for the discovery of consumer products enhancing taste and olfaction. more
LA JOLLA (Sept. 14, 2000) – SenomyxSM, Inc. announced today the completion of a $10,000,000 private placement of Series B preferred stock. The private placement was led by Dr. Alejandro Zaffaroni. more
LA JOLLA (Sept. 14, 2000) SenomyxSM, Inc. announced that Dr. Richard A. Lerner, President of The Scripps Research Institute, has joined the company's Scientific Advisory Board. more
LA JOLLA (Sept. 14, 2000) – SenomyxSM, Inc. announced today the completion of an expanded long-term lease on its current laboratory and office facilities located in the heart of the San Diego scientific community. more
LA JOLLA (June 28, 2000) – SenomyxSM, Inc. announced today the appointment of Klaus Gubernator, Ph.D. to the position of Vice President, Chemistry. Dr. Gubernator will direct Automated Chemistry, Chemoinformatics, Bioinformatics,and High Throughput Screening. more
LA JOLLA (May 9, 2000) – SenomyxSM, Inc., announced today the formation of a distinguished group of scientific advisors that will work closely with Senomyx management to support the company's scientific and business strategies. more
LA JOLLA (May 9, 2000) – SenomyxSM, Inc. announced today the appointment of Mark J. Zoller, Ph.D., former Director of the Aventis Genomics Center in Cambridge, MA. As Vice President of Research, Dr. Zoller will direct all research operations of the company including genomics, biology, chemistry, and informatics. more
LA JOLLA (May 9, 2000) – SenomyxSM, Inc. announced today that Dr. David Schnell, Managing Partner, Prospect Venture Partners and Mr. Kevin C. Tang, Managing Director at Deutsche Banc Alex. Brown have joined the Board of Directors of the company. more
LA JOLLA (May 9, 2000) – SenomyxSM, Inc. announced today that it has acquired rights to novel sodium channel related technology developed in the laboratories of Dr. Solomon Snyder at Johns Hopkins University. more
LA JOLLA (May 9, 2000) – SenomyxSM, Inc. announced today that the company has completed its sublease of laboratory and office facilities and has relocated its headquarters and all operations to a nearly 16,000 square foot facility located at 11099 North Torrey Pines Road, La Jolla, California 92037. more
LA JOLLA (March 16, 2000) – Ambryx Inc. announced today that it has acquired rights to a new family of candidate taste receptors and related technologies from the University of California. more
SAN DIEGO (October 25, 1999) – Ambryx Inc. announced the signing of an exclusive agreement with Johns Hopkins University regarding enabling technology and molecules related to chemosensation and olfaction. more
SAN DIEGO (October 25, 1999) – Ambryx Inc. announced today the completion of a $12,275,000 private placement of Series A preferred stock. The placement represents one of the largest initial rounds of financing for a company in the biotechnology field in 1999. more
SAN DIEGO (May 7, 1999) – Ambryx Inc. announced today the completion of initial seed financing for the company. The funding was raised through premier venture capitalists including Domain Associates, Kingsbury Associates and Kevin J. Kinsella. more
SAN DIEGO (April 15, 1999) – Ambryx Inc. announces today the signing of an exclusive agreement with the University of California regarding a set of novel molecules involved in the biology of taste, including two candidate taste receptors. more